Shire Share News (SHP)

9 Nov 2016

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets) ...

9 Nov 2016

* Clinton was seen more likely to curb drug costs than Trump * California drug pricing move also heading for defeat By Ben Hirschler LONDON, Nov 9 (Re...

3 Nov 2016

(ShareCast News) - Credit Suisse downgraded retailer Next to 'underperform' from 'neutral' and slashed the price target to 4,600p from 4,950p. The ban...

3 Nov 2016

(ShareCast News) - Shire got a boost on Thursday as Bank of America Merrill Lynch added the stock to its 'Europe 1' list with a 'buy' rating and 6,970...

2 Nov 2016

LONDON, Nov 2 (Reuters) - Four patients have suffered serious adverse events in a clinical trial of an experimental haemophilia medicine from Roche, t...

1 Nov 2016

* Q3 revenue misses forecasts * Sales of Baxalta's haemophilia products disappoint * Company sticks to full-year earnings target * Shares recover some...

1 Nov 2016

LONDON, Nov 1 (Reuters) - Drugmaker Shire met market expectations by reporting third-quarter earnings per share of $3.17, down 2 percent on a year ago...

1 Nov 2016

(ShareCast News) - Third-quarter revenues and earnings from Shire were just shy of forecasts, while the drug developer did not raise guidance as some ...